CrossrefInfokarte
Response to Letters to the Editor Regarding ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From a Multi‐Center, Prospective, Observational Study ( REVISE Study)’
Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)
DOI: 10.1002/edm2.70300 ↗Abstract
Kein Abstract verfügbar.
EUVIMED